India Glycols Ltd (BSE: 500201, NSE: INDIAGLYCO) — Company Filings / Investor Feed

Sector: Beverages - Fast Moving Consumer Goods

BSE Code: 500201

NSE Symbol: INDIAGLYCO

ISIN: INE560A01023

India Glycols Ltd

📄 India Glycols faces GST penalty of Rs. 6,22,080; will appeal - GST penalty order dated 10th October 2026: Rs. 6,22,080 - Order from State Tax Officer, SGST Dept, Uttarakhand - Vehicle at Singhniwala, Uttarakhand carried goods against 3 invoices - Transporter missed Part-B update in e-way bill f…

India Glycols Ltd

🔍 India Glycols tells NSE/BSE: No undisclosed material info; price move market-driven - Clarification requests from NSE and BSE dated 8th October 2026 - No material information remains undisclosed as per SEBI Listing Regulations - Not aware of specific reason for share price movement - Share pric…

India Glycols Ltd

📄 India Glycols: Cost allocation guidance for demerger with Ennature Bio & IGL Spirits - Scheme of arrangement effective from 1 Sep 2026 - Record date for allotment: 2 Sep 2026 - Allotment ratio: 1 Ennature share per 3 India Glycols shares - Allotment ratio: 1 IGL Spirits share per 1 India Glycol…

India Glycols Ltd

📅 India Glycols Ltd moves analyst meets to virtual mode - Analyst meets moved to virtual from in-person. - Scheduled for Oct 7-8, 2026 (dates unchanged). - All other details per prior intimation dated Oct 1, 2026.

India Glycols Ltd

India Glycols Ltd sets Non-Deal Roadshow in Mumbai 📅 - Non-Deal Roadshow scheduled for Oct 7-8, 2026 - Meetings in Mumbai (in-person) - Discussions based on public information only

India Glycols Ltd

🤝 India Glycols Ltd to Hold Non-Deal Roadshow in Singapore - Non-Deal Roadshow on 28th & 29th Sep 2026 in Singapore - Meetings with analysts and institutional investors - Discussions based on publicly available info only (no UPSI)

India Glycols Ltd

🏭 India Glycols Ltd invites investors & analysts for plant visit (Sept 19-20) - Plant visit for investors & analysts on Sept 19-20, 2026 - Locations: Kashipur and Dehradun

India Glycols Ltd

India Glycols' arm EBL allots 2,23,42,255 shares in 1:3 ratio, appoints CFO & CS - EBL allots 2,23,42,255 shares (₹5) in 1:3 ratio to India Glycols holders (2nd Sep 2026) - Shri Ajay Sharma appointed as CFO & KMP effective 8th Sep 2026 - Smt. Preeti Choudhary appointed as CS, KMP & Compliance Offi…

India Glycols Ltd

📢 IGSL Allots 6,70,26,765 Equity Shares to India Glycols Shareholders | Key Appointments - IGSL allotted 6,70,26,765 equity shares at INR 5 each (1:1 ratio) - Record date: 2nd September 2026 - Allotted shares rank pari passu with existing IGSL shares - Appointed Shri Naresh Kumar Agrawal as CFO &…

India Glycols Ltd

India Glycols Ltd to Host Non-Deal Roadshow in Mumbai 📅 - Non-Deal Roadshow on Sep 10-11, 2026 - In-Person meetings in Mumbai

India Glycols Ltd

📬 India Glycols Ltd receives material update from Ennature Bio Pharma - IGL received communication from EBL dated 7th Sept 2026 - Communication contains material events/updates on EBL - Disclosure relates to a Scheme of Arrangement

India Glycols Ltd

📬 India Glycols Ltd receives material update from IGL Spirits Ltd - IGL received letter from IGSL (dated 7th September 2026) on material updates

India Glycols Ltd

India Glycols: 13% Revenue CAGR, 28% EBITDA CAGR, and a 10X Vision 📈 - Revenue CAGR ~13% (FY24-FY26) - EBITDA CAGR ~28% (FY24-FY26) - IGL capacities: 70,000 MTPA Glycols, 7,500 MTPA specialty unit - Bio-Glycol Ethers FY26: INR 221 Cr sales, ~18,000 MT volume (89% domestic) - Performance Chemicals…

India Glycols Ltd

India Glycols Aims for 10X Growth: ₹2,000 Cr Revenue & ₹400 Cr EBITDA Target 📊 - Vision to achieve 10X sales and profits in ten years - Aiming for ₹2,000 Cr net revenue in 4-5 years - Aiming for ₹400 Cr EBITDA in 4-5 years - Revenue grew at ~13% CAGR over FY24-FY26 - EBITDA grew at ~28% CAGR over…

India Glycols Ltd

📊 India Glycols Ltd: FY26 Revenue ₹5,153 Cr, EBITDA ₹428 Cr; Bio-fuels Orderbook of ₹1,450 Cr - FY26 Revenue: INR 5,153 Cr, EBITDA: INR 428 Cr, PAT: INR 210 Cr - Gross Margin: 45.9% (FY26) - Bio-fuels allocation: ~220mn Ltrs valued at INR 1,450 Cr - Aspiration: EBITDA > INR 550 Cr by FY27 - Debt-…

India Glycols Ltd

📊 India Glycols' Ennature Biopharma: Future Guidance – APIs, Nutraceuticals & Biopolymers - Ennature Biopharma: demerged integrated natural ingredients platform (3 businesses) - API business targets one new API per year, deeper regulated markets - Leadership in Thiocolchicoside, Colchicine, Nicot…

India Glycols Ltd

🔄 India Glycols Ltd: Key Management Changes Effective 31 Aug 2026 - SMPs ceased from 31 Aug 2026 (close of business) - Transfer to resulting companies effective 1 Sep 2026 - Shashi Kant Shukla (Business Head - Gorakhpur) ceased - Shailendra Kumar Pandey (Head-Distillery, Gorakhpur) ceased - Visha…

India Glycols Ltd

India Glycols Demerger Takes Effect: Three New Entities from Sept 1 🔄 - Demerger effective 1st September 2026 - IGL Spirits net revenue: ₹694 crore (June 2026 quarter) - India Glycols net revenue: ₹345 crore (June 2026 quarter) - Ennature Bio Pharma net revenue: ₹90 crore (June 2026 quarter) - Re…

India Glycols Ltd

📅 India Glycols Ltd to Host Analyst Meeting in Mumbai on Sept 2, 2026 - Analyst/Investor meeting on 2nd Sep 2026 at 5:00 PM IST - Physical group meeting in Mumbai - Discussions based on public info, no UPSI - Meeting details on company website

India Glycols Ltd

India Glycols Demerger Gets NCLT Nod 🏛️ | New Structure Takes Shape - NCLT, Allahabad Bench, has approved the Scheme of Arrangement (demerger) for India Glycols Limited. - The demerger splits the company into two new resulting companies. - The Biopharma Undertaking will be transferred to Ennature…